Background: Esthetic outcome associated with dental implant in type 2 diabetic patients remained uninvestigated.
INTRODUCTION
Dental implants are a commonly used treatment modality for management of fully and partially edentulous patients in modern dental clinics. [1] [2] [3] [4] To assure the long-term clinical success, good initial stability, healing of soft tissue immediately following implant placement, and osseointegration are crucial. [5] [6] [7] [8] In the anterior maxilla, initiation and preservation of appropriate hard and soft tissue architecture are substantial to attain pleasing esthetic outcomes. Appropriate bone dimension and architecture of the alveolar edentulous ridge, comprising an intact facial bone wall of sufficient thickness and height in combination with a correct restoration-driven implant placement, are mandatory to support periimplant soft tissue. [9] [10] [11] [12] [13] Careful patient selection with proper wound healing and without any metabolic disorders should be considered for long term clinical success of dental implant. 14, 15 Several medical conditions able to interfere with normal body reaction following surgical intervention which require careful evaluation after surgery. These conditions call for precise estimation but not spontaneously hinder implant therapy in every influenced individual. 15, 16 Diabetes mellitus is a long-term metabolic disturbance that is essentially distinguished by insulin impedance, relative insulin insufficiency, and elevated levels of blood glucose (hyperglycemia). 18, 19 Diabetic patients have increased frequency of delayed wound healing, impaired response to infection, and periodontal inflammatory conditions with subsequent tooth loss. 15, [20] [21] [22] 23 Many researchers reported direct relation between diabetic patients and failure of dental implant. [24] [25] [26] [27] However Alasqah et al 28 evaluated delayed loaded dental implant treatment in diabetic patients after a 6-year of clinical observation, they concluded that when glycemic levels of type 2 diabetic patients are carefully controlled and maintained, the prognosis of implant therapy in esthetic area can remain functionally stable and esthetically pleasant in a manner similar to healthy individuals.
Safety replacement of missing teeth with an implant, as a treatment modality, with or without osseous augmentation steps in patients' with diabetes is yet controversial. Normal wound healing following implant surgery is required for osseointegration. The host bed requires an adequate blood supply to deliver the necessary elements for wound repair and host defense. 29, 30 Diabetic has been shown to impair wound healing; therefore, it may also impair osseointegration. Furthermore, diabetic has been implicated in reduced bone density, possibly giving rise to poor quality bone. Poor bone quality has been attributed to implant loss. The target of this clinical investigation was to evaluate prospectively clinical and esthetic outcome of dental implant placement in esthetic zone in relation to controlled diabetic.
MATERIALS AND METHODS

Study design
This prospective, controlled clinical trial in which patients were consecutively included based on certain inclusion and exclusion specifications. After getting ethical approval from the Research Ethics Committee at faculty of dentistry, Mansoura university, forty patients were picked from the faculty outpatient clinic. The patients have been asked and accepted to participate in the research in a consecutive schedule, provided they redeem the subsequent criteria: inclusion criteria; either systemically healthy individuals (group H) or patients with controlled diabetics (type 2, group D), who are on active medical treatment and receiving oral hypoglycemic. Their previous diabetes history was confirmed with the physician's report. Preoperative Glycated hemoglobin A1c (HbA1c) levels were between 6% and 7.5%. HbA1c levels of the patients were measured 1 week before surgery, 3-5 months after implant placement and during follow up interval at the same laboratory.
All the patients are in need of an implantsupported single tooth restoration within anterior maxilla, have either sufficient bone volume and /or with labial bone defect (with at least 10 mm osseous height but less than 5 mm osseous width).
CBCT was used for every patient to check for the bone volume and aid in surgical template fabrication. (Fig. 1 ) Exclusion criteria: Alcohol or drug abuse, other systemic conditions which interfere with the surgical procedure, presence of any systemic contraindication other than diabetes, the individual is not able to give her/his informed consent to participate, smokers and bruxism or other destructive oral habits.
Surgical interventions
Before surgery, the patient received antibiotics (2 x 625 mg Augmentin®, Galaxo Smith Kline Co). Patients were instructed to use mouthwash (Orovex, Macro-International Co). Surgery was performed under local anesthesia (Ubistesin forte, 3M ESPE). A full-thickness flab was raised followed by osteotomy preparation and implant installation (HEXACONE, IHDEDENTAL, Switzerland) following manufacturer's recommendation. (Fig. 2) In groups D2 and H2, the space between the fixture and the labial bone was loaded with xenograft bone substitute (tutobone; tutogen, germany) and the resorbable membrane were placed. After six months, the implant was uncovered and the healing cap was inserted. After two weeks, the prosthetic phase was started by impression making and definitive restoration was constructed.
Evaluation phase
Clinical follow-up was carried at 6 months after implant placement with definitive restorations, 12 months and finally after 24 months ( Fig. 3 ). At each recall appointment, both clinical and periapical radiographic examinations were evaluated.
Peri-implant clinical indices: Modified plaque index (mPI) 31 : 0 = no plaque detected, 1 = plaque detected by running a probe across the surface.; 2 = plaque was observed visually.; 3 = abundance of plaque. The presence of plaque was detected by running a probe along the smooth marginal surface of the implant. The probing was assessed four sites around each implant (mesial, labial, distal and lingual). The sum of the four probing surfaces were calculated was divided by four to get the average score around each implant.
Radiographic evaluation
Using standard periapical radiographs, the marginal bone loss (MBL) was evaluated at 6 months, 12 months and finally after 24 months. The changes in the marginal bone around implant were measured according to the following: 32 Two reference points (one mesial and one distal) at implant / abutment junction was used as reference points. A straight line was established between the two reference points which represent the baseline height. Mesial and distal perpendicular lines were created running from the line that represented baseline height to the most coronal point of bone contact. MBL was calculated by subtracting the two measurements. Both mesial bone loss and distal bone loss were determined; the larger of the two values was considered the bone loss of the implant in question.
Esthetic evaluation
Assessment of esthetic results were rated employing pink esthetic score (PES) and white esthetic score (WES) [33] [34] [35] . A front and occlusal color views photographs was taken for every case with high resolution camera and the images were then transported to a computer with an enhanced resolution screen for screening and estimation. All clinical measurements were evaluated by a blinded, expert examiner.
Statistical Methods
In order to perform the descriptive statistical analysis, all data were entered in a Microsoft Excel 2010 worksheet. For further data analysis statistical package for social science version 20 SPSS (SPSS, IBM Corp., New York) was used. For mPI,PES/ WES Wilcoxon signed rank test was used while two way mixed analysis of variance (ANOVA) was used for analysis of MBL at 5% level of significant. 
RESULTS
With 40 implants, our study had 40 patients (18 men, 22 women) with a mean age of 40±7 years at the time of implant placement (table. 1). The mean time from surgery to evaluation was 30 months starting from August 2016 till November 2018. At the end of evaluation period, no implants were lost through the observation interval and all fixtures were well integrated giving rise to a 100% implant survival after 24 months of function after implant placement. The biological integration of all implants was excellent with no biological complications at implant sites. 
Plaque index
All groups have minimal rise in the proportion of plaque during 24 months of evaluation and the difference between study groups was insignificant (table 2) . Also, there were no significant differences for probing depth among all study groups.
Marginal level bone changes
The marginal bone loss was measured and the means of MBL was obtained at 6 months, one year and two years. The mean values of MBL are represented in table 3 at each time interval. When comparing implants placed in controlled diabetic versus implants placed in healthy individuals, it was found that, the level of marginal bone surrounding implants in controlled diabetic with and without bone augmentation decreased by 0.74±0.11 and 1±0.16 mm respectively, while in healthy individuals the decreased was 0.62±0.07 and 0.45±0.08 mm in groups H1 and H2 respectively and the difference was statistically significant (p=0.001).
Overall evaluation period, the bone loss in controlled diabetic patients were significantly greater (p=0.001) than that demonstrated surrounding the implants in healthy individuals regardless the augmentation procedure.
PES/WES
The detailed PES/WES scores of the 40 examined single-tooth implants are showed in Table 4 . The mean total PES was for healthy individuals with and without bone augmentation was 7.3 and 7.2 respectively, while for controlled diabetic patient was 6.4 and 6.3 for respectively. For the WES, the mean total was 8. Poor bone volume and anatomic deviations are frequently met during implant placement in maxilla. In light of the concerns surrounding diabetes, bone grafting, guided tissue regeneration, and bone healing, the present study is a prospective clinical trial to compare between single tooth implant placement in anterior esthetic region in controlled type 2 diabetic and healthy patient using bone graft augmentation (xenograft) and guided tissue regeneration (resorbable).
The procedures of tissue augmentation are recommended to compensate the expected bone resorption and maintain the integrity of the osseous plate dimension in esthetic zones. An efficient regenerative protocol is the milestone to restore both the hard and soft tissue dimensions and preserve the good esthetic results over time. 13, 36 In the current study, xenograft bone substitute and resorbable membrane were used in both groups because the xenograft act as osteoconductive scaffold and beside that it would not resorbed during the normal bone remodeling. 37 Moreover, several authors have reported that a xenograft particulate material placed into the buccal space minimizes the amount of osseous collapse. 38, 39 The results of this present study revealed that PI and crestal bone loss were significantly higher in controlled diabetics than in the normal individual group.
MBL in controlled diabetic groups were significantly higher than in controlled diabetic normal groups especially after 6 months in the present study. Our results were in accordance with Mokeem et al, who reported that radiographic bone loss was increased in diabetic patients compared to healthy individuals. 20 PES ̸ WES includes the assessment of the periimplant soft tissues and the implant-supported restoration to allow an inclusive esthetic assessment. Data of our study pointed out that there was no worthy variation among the study groups with regards to WES. The level of mid-facial mucosal height with mesial papillae were awarded the lowest scores for both groups, which may be caused by the mild degree of soft tissue regression that was encountered in the two groups at the end of follow up period. When counterweighting the total mean PES among the study groups, no worthy variation was detected. The lowest score for the two studied groups was linked with the color of the implant crown, which has also been reported by Cosyn et al. (2012) 40 and Raes et al. (2011) . 41 The color of the restoration is dependent on the process of shade matching with surrounding teeth which, in turn, based on quality and experience of the operator and the dental technician fabricating the restoration. Optimal shade matching, which would express as high WES score for color, may be difficult to realize since it depends on variety of factors as the required type and thickness of the ceramic material 42 to get the desired esthetics and the shade taking device. 43 Furthermore, in spite of the utilizing of shade tap as a conventional technique to record the shade of the prospective ceramic crown, this technique stills highly subjective and is obvious in our low WES for Color. 44 The authors are aware that future controlled investigations with a larger number of patients in the diabetic group are needed to assure the real effect of the condition on the dental implant outcome in various clinical situations with more implants systems offering variety of surface treatments.
CONCLUSIONS
Single tooth dental implants can remain functionally and esthetically acceptable in type 2 diabetic patients in a manner similar to healthy patients provided carful controlling and maintaining of blood glycemic level.
